Acumen Pharmaceuticals In...

1.16
-0.12 (-9.38%)
At close: Mar 03, 2025, 3:59 PM
1.15
-0.86%
After-hours: Mar 03, 2025, 04:00 PM EST

Acumen Pharmaceuticals Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio -3.56 -5.42 -1.51 -110.19 -102.65
PEG Ratio -0.44 0.07 -0.00 11.02 n/a
PS Ratio n/a n/a n/a 562.01 475.58
PB Ratio 0.70 1.16 1.22 -43.41 -70.67
P/FCF Ratio -4.32 -6.21 -15.2 -108.33 -118.37
P/OCF Ratio -4.32 -6.24 -15.23 -108.33 -118.37
OCF/S Ratio n/a n/a n/a -5.19 -4.02
Debt / Equity Ratio 0.11 0.00 n/a n/a n/a
Quick Ratio 19.01 23.08 38.60 6.98 5.35
Current Ratio 19.01 23.08 38.60 6.98 5.35
Asset Turnover n/a n/a n/a 0.03 0.23
Interest Coverage n/a n/a n/a n/a n/a
Return on Equity (ROE) -0.2 -0.21 -0.81 0.39 0.69
Return on Assets (ROA) -0.17 -0.21 -0.79 -0.16 -1.07
Return on Capital (ROIC) -0.21 -0.24 0.27 -0.21 -1.31
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a 99.44% 99.49%
Net Profit Margin n/a n/a n/a -510.03% -463.29%
Pretax Profit Margin n/a n/a n/a -510.1% -465.94%
Operating Profit Margin n/a n/a n/a -550.97% -459.93%
FCF Margin n/a n/a n/a -518.8% -401.77%
EBITDA Margin n/a n/a n/a 40.88% 7.01%